Suven Life up 5% on three product patents

Suven Life Sciences rallied as much as 4.6 percent intraday amid heavy volumes on Monday as the company has secured three product patents (two from Eurasia and one from Canada) corresponding to the new chemical entities for the treatment of disorders associated with Neurodegenerative diseases.

December 31, 2012 / 14:55 IST

26 Aug, 2025 12:21

Volume

Todays L/H

Suven Life Sciences rallied as much as 4.6 percent intraday amid heavy volumes on Monday as the company has secured three product patents (two from Eurasia and one from Canada) corresponding to the new chemical entities for the treatment of disorders associated with Neurodegenerative diseases.

These patents are valid through 2027, says the company in a release. With these new patents, Suven has a total of 10 granted product patents from Canada and 12 from Eurasia.

At 14:38 hours IST, the stock rose 2.8 percent to Rs 31.25 on the Bombay Stock Exchange. Trading volumes increased 263 percent to 3,75,512 equity shares as compared to its five day average of 103,330 shares.

first published: Dec 31, 2012 02:54 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

Al Edge Newsletter On Saturdays

Find the best of Al News in one place, specially curated for you every weekend.
MC Tech 3 Newsletter Daily-Weekdays

Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347